These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 10632321

  • 1. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells.
    Ghetie MA, Ghetie V, Vitetta ES.
    Clin Cancer Res; 1999 Dec; 5(12):3920-7. PubMed ID: 10632321
    [Abstract] [Full Text] [Related]

  • 2. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW, Allen TM.
    J Control Release; 2008 Feb 18; 126(1):50-8. PubMed ID: 18068849
    [Abstract] [Full Text] [Related]

  • 3. An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line.
    Ghetie MA, Marches R, Kufert S, Vitetta ES.
    Blood; 2004 Jul 01; 104(1):178-83. PubMed ID: 15001473
    [Abstract] [Full Text] [Related]

  • 4. Mutational analysis of P-glycoprotein: suppression of caspase activation in the absence of ATP-dependent drug efflux.
    Tainton KM, Smyth MJ, Jackson JT, Tanner JE, Cerruti L, Jane SM, Darcy PK, Johnstone RW.
    Cell Death Differ; 2004 Sep 01; 11(9):1028-37. PubMed ID: 15131592
    [Abstract] [Full Text] [Related]

  • 5. CD19 monoclonal antibody HD37 inhibits anti-immunoglobulin-induced B cell activation and proliferation.
    Pezzutto A, Dörken B, Rabinovitch PS, Ledbetter JA, Moldenhauer G, Clark EA.
    J Immunol; 1987 May 01; 138(9):2793-9. PubMed ID: 2437199
    [Abstract] [Full Text] [Related]

  • 6. Generation of multidrug resistant lymphoma cell lines stably expressing P-glycoprotein.
    Pop I, Pop L, Vitetta ES, Ghetie MA.
    Oncol Rep; 2008 Apr 01; 19(4):889-95. PubMed ID: 18357372
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional modulation of ATPase of P-glycoprotein by C219, a monoclonal antibody against P-glycoprotein.
    Kokubu N, Cohen D, Watanabe T.
    Biochem Biophys Res Commun; 1997 Jan 13; 230(2):398-401. PubMed ID: 9016791
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Discovery and characterization of OC144-093, a novel inhibitor of P-glycoprotein-mediated multidrug resistance.
    Newman MJ, Rodarte JC, Benbatoul KD, Romano SJ, Zhang C, Krane S, Moran EJ, Uyeda RT, Dixon R, Guns ES, Mayer LD.
    Cancer Res; 2000 Jun 01; 60(11):2964-72. PubMed ID: 10850444
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mitochondrial localization and activity of P-glycoprotein in doxorubicin-resistant K562 cells.
    Munteanu E, Verdier M, Grandjean-Forestier F, Stenger C, Jayat-Vignoles C, Huet S, Robert J, Ratinaud MH.
    Biochem Pharmacol; 2006 Apr 14; 71(8):1162-74. PubMed ID: 16499877
    [Abstract] [Full Text] [Related]

  • 16. HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    Lee CG, Gottesman MM, Cardarelli CO, Ramachandra M, Jeang KT, Ambudkar SV, Pastan I, Dey S.
    Biochemistry; 1998 Mar 17; 37(11):3594-601. PubMed ID: 9530286
    [Abstract] [Full Text] [Related]

  • 17. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318.
    Chen LM, Liang YJ, Ruan JW, Ding Y, Wang XW, Shi Z, Gu LQ, Yang XP, Fu LW.
    J Pharm Pharmacol; 2004 Aug 17; 56(8):1061-6. PubMed ID: 15285852
    [Abstract] [Full Text] [Related]

  • 18. Reversal of P-glycoprotein-mediated multidrug resistance by Alisol B 23-acetate.
    Wang C, Zhang JX, Shen XL, Wan CK, Tse AK, Fong WF.
    Biochem Pharmacol; 2004 Sep 01; 68(5):843-55. PubMed ID: 15294447
    [Abstract] [Full Text] [Related]

  • 19. Reversal of P-glycoprotein-mediated multidrug resistance by a synthetic α-aminoxy peptidomimetic.
    Ma B, Chai S, Li N, To KK, Kan WL, Yang D, Lin G.
    Int J Pharm; 2012 Mar 15; 424(1-2):33-9. PubMed ID: 22226881
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.